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Abstract 
High-throughput molecular studies are greatly advancing our knowledge of the human 
microbiome and its specific role in governing health and disease states. A myriad of ongoing 
studies aim at identifying links between microbial community disequilibria (dysbiosis) and 
human diseases. However, due to the inherent complexity and heterogeneity of the human 
microbiome we need robust experimental models that allow the systematic manipulation of 
variables to test the multitude of hypotheses arisen from large-scale ‘meta-omic’ projects. 
The nematode C. elegans combined with bacterial models offers an avenue to dissect cause 
and effect in host-microbiome interactions. This combined model allows the genetic 
manipulation of both host and microbial genetics and the use of a variety of tools, to identify 
pathways affecting host health. A number of recent high impact studies have used C. 
elegans to identify microbial pathways affecting ageing and longevity, demonstrating the 
power of the combined C. elegans-bacterial model. Here I will review the current state of the 
field, what we have learned from using C. elegans to study gut microbiome and host 
interactions, and the potential of using this model system in the future.  
 
Introduction 
Humans coexist in a mutualistic relationship with a diverse gut microbial ecosystem 
consisting of mainly bacteria, but also viruses, fungi and protozoa. The gut microbiome 
consists of more than 5 million genes, a genome that is two orders of magnitude than the 
human genome1. The interactions between the host and the microbiota is highly 
interdependent and it has been suggested that humans should be considered as 
superorganisms in which the microbial symbionts play essential physiological functions2. The 
microbiome can directly affect host physiology by providing food and essential metabolic 
compounds and inhibiting pathogen colonization by limiting resources available to the 
invading microbes or competing for attachment sites on the surface of intestinal epithelial 
cells, or by directly modulating immune system maturation. Conversely, the microbiome has 
been found to be associated with chronic inflammation3 and dysbiosis, and imbalance in the 
microbiome has been linked to diseases such as inflammatory bowel disease, diabetes 
mellitus, obesity, cardiovascular disease and cancer1.  
Our current understanding of the human gut microbiota mainly relies on metagenomics 
profiling. Over the last decade, large-scale metagenomics sequencing studies of human 
faecal samples have identified many hundreds of species, common sets of microbial 
species, as well as inter-individual variation. Combined data from the MetaHit and the 
Human Microbiome Project have provided the most comprehensive view of the composition 
of the human gut microbiota, identifying a total of 2172 species isolated from human beings, 
classified into 12 different phyla, of which the large majority belong to the phyla 
Proteobacteria, Firmicutes, Actinobacteria and Bacteroidetes4–7. Further studies have used 
functional omic approaches to attempt to determine which microbial species that are active 
by identifying microbial proteins and metabolites in faecal samples8–11, and how microbial 
metabolites are affected in disease states12. Together these approaches are generating 
many hypotheses regarding the association between the composition of the gut microbiota 
and human health. 
 
The gut microbiota is linked to the ageing process 
Considering the many physiological effects of the gut microbiota, it is not surprising that the 
gut microbiota is also linked to the ageing process of the host. The composition of the gut 
microbiota changes dramatically during ageing13. Healthy gut microbiota is characterised by 
bacterial taxonomic diversity, while age and frailty is associated with Bacteroidetes 
dominated populations, expansion of more pathogenic bacterial species and a much larger 
variation between individuals14,15. Studies of centenarians have shown that their microbiota 
differs from those of older adults16,17, consistent with general age-related microbiota trends. 
The numerous metagenomic studies have enabled the definition of a healthy baseline 
microbiota and generated many hypotheses regarding the association between the 
composition of the gut microbiota, diseases and the ageing process. These hypotheses 
include effects on frailty15, gut health16, brain plasticity and cognitive function18, 
inflammation16, metabolic syndrome19, immunity20 and longevity16. We now need robust 
experimental models that allow the systematic manipulation of variables to test the 
hypotheses arisen from large-scale metagenomic projects and identify the molecular 
mechanisms underlying the effects of microbial genes on general health and ageing3. 
 
Available models to study the effect of the gut microbiota on ageing 
Germ-free (GF) mice are the most commonly used animal models to study host-microbe 
interactions. GF mice are raised in sterile conditions, have no microorganisms living in them 
and can be made gnotobiotic by colonization with single microbial species, allowing the 
impact of specific microorganisms to be studied. These kind of studies have shown that the 
gut microbiota is important for a number of physiological processes in the host including 
homeostasis, immune system function, development and metabolism1. The main challenges 
with using this model is that maintaining the mice sterile is an expensive and labour 
intensive challenge, making it a slow, tedious and low-throughput approach. Laboratory mice 
have a lifespan of approximately 3 years, making the use of gnotobiotic mice in ageing 
studies even more cost some and challenging21.  
In addition to mice, zebra fish is being established as a model organism to study ageing 
and the microbiota, but with a lifespan similar to the mouse lifespan, and tank-based 
husbandry, it also offers a slow low-throughput approach. Therefore, complementary 
approaches allowing unbiased high-throughput methods are needed, which can elucidate 
the mechanisms underlying host-microbiota interactions in vivo22.  
The nematode C. elegans offers an avenue to dissect the cause and effect by allowing 
the genetic manipulation of both host and microbial genetics to identify pathways affecting 
host health. A number of recent studies have identified microbial pathways affecting ageing 
and longevity in C. elegans (Table 1), opening for the possibility to further develop this 
model to understand the role of the gut microbiota in disease states and ageing. Here I will 
review the current state of the field, what we have learned so far from using the nematode to 
study gut microbiome and host interactions, and how C. elegans can be further exploited to 
dissect of complex interactions and mechanisms between the host and its microbiota. 
 
The worm-bug: A high throughput model of host-microbiota interactions 
The nematode C. elegans has many inherent advantages as a model. It has a short life 
cycle of three days, a large brood size and a lifespan of three weeks, and is inexpensive and 
easy to cultivate in the laboratory. C. elegans has two sexes: the hermaphrodite, which is 
self-fertilizing and isogenic, and males, allowing genetic exchange and genetic crosses. C. 
elegans is transparent, allowing imaging of tissues and cells in vivo, without the need of 
dissection. This model organism also offers many useful tools to dissect complex biological 
pathways. There are publicly available genetic mutants from the Caenorhabditis Genetics 
Center, and genome wide RNA interference libraries23, allowing high-throughput genetic 
screens. Many additional tools have been developed allowing high-throughput approaches 
of e.g. survival measurements24,25. The body of C. elegans is transparent, allowing the use 
of fluorescent reporters in vivo. Importantly, C. elegans is well-established as an ageing 
research model and has enabled the identification of pathways influencing ageing, such as 
the insulin/IGF-1 (IIS) and mTOR pathways, which are evolutionary conserved in 
mammals26. Approximately 50% of the C. elegans genes have clear human orthologues, 
making C. elegans ideal to study pathways highly relevant to human biology.  
C. elegans is a bacterivore, and in the wild C. elegans feeds on bacteria that proliferate 
in decaying organic material, and harbour a diverse bacterial flora in their guts27. In terms of 
the viability and evolution of C. elegans and its microbes, it is regarded as an indivisible 
entity, called the “worm-bug”28. In addition to all the advantages C. elegans offers on its own 
as a laboratory model system, it has been combined with another very successful model, E. 
coli. In the laboratory, C. elegans is maintained on a monoxenic culture, typically of the 
Escherichia coli B bacterial strain OP50, using standard microbiology techniques. In 
addition, other strains such as Bacillus subtilis and E. coli HT115 are also routinely used28. 
The easily obtained control of the gut microbiota in C. elegans allows the dissection not only 
of host pathways, but also of bacterial pathways, and complex interactions between the host 
and the microbiota. E. coli is the most thoroughly studied species on the planet, has well-
established genetics and offers many tools such as genome editing, genetic engineering and 
online databases for analysis of genetic and biochemical functions. Combining the 
advantages of E. coli and C. elegans into the worm-bug model system is proving to yield a 
very powerful combined model system. For example, the E. coli Keio deletion collection 
containing approximately 4000 mutants covering 93% of E. coli genes can be used to screen 
for host phenotypes, and this approach has successfully been used to identify bacterial 
pathways affecting C. elegans ageing29,30. This approach is not limited to E. coli, as there are 
additional collections in other species31.  
The use of the worm-bug model consisting of a host with a single microbial species as its 
microbiota offers many advantages in terms of experimental tractability. Furthermore, 
inexpensive and straight forward cultivation, combined with the short lifespan of C. elegans, 
makes this model system an ideal addition to existing mammalian models to dissect the role 
of the gut microbiota in human health and ageing. Recent years have seen several high-
profile studies using the worm-bug, identifying a number of bacterial and host interactions 
promoting host longevity.  
 
Bacterial folate metabolism promotes longevity  
One of the most well studied microbial pathway to affect C. elegans longevity is folate 
metabolism. The folate cycle is a series of metabolic steps found in all cells, including both 
bacteria and animals, required for cell biosynthesis. The products include purines, 
pyrimidines, glycine, and methionine, and are required to generate the methyl donor 
molecule S-adenosyl methionine (SAM), which occupies a central role for metabolism of all 
cells. Folates in their reduced tetrahydrofolate form act as enzymatic cofactors in the folate 
cycle, and since animals cannot synthesize folates, folates are obtained from their diets and 
microbiota32. 
Disruption of E. coli folate synthesis promotes longevity in C. elegans. Para-
aminobenzoic acid (PABA) is a folate precursor. A partial screen of the Keio E. coli mutant 
library identified several mutations in enzymes involved in the synthesis of PABA, aroD, 
pabaA and pabaB, which increase lifespan in C. elegans. Sulfamethoxazole (SMX), a 
sulfonamide drug that competes with PABA for the active site of the enzyme dihydropteroate 
synthase, also increases lifespan in C. elegans. Reducing folate uptake or metabolism 
directly in the host does not affect lifespan, showing that lifespan is extended as a result of 
alterations in bacterial metabolism29,32.  
Important clues regarding the mechanisms underlying bacterial folate metabolism and 
host ageing have come from studies using the biguanide metformin, an oral drug widely 
prescribed to treat type 2 diabetes. The biological activity of metformin goes beyond its 
antihyperglycemic effects, and has been shown to reduce the risk of cancer33 and delay 
ageing in rodents34. Metformin also extends lifespan in C. elegans35, and this effect is 
dependent on bacterial activity. In the absence of E. coli, or in the presence of dead E. coli, 
metformin is toxic and shortens lifespan. A key player in this bacterial effect is folate 
metabolism; Metformin does not increase lifespan when mutations in folate cycle enzymes 
are introduced into E. coli and pharmacological inhibition of folate synthesis in E. coli mimics 
metformin treatment. Furthermore, metformin changes the folate composition in E. coli, but 
not in C. elegans. Changes in the folate cycle result in perturbations of bacterial methionine 
metabolism, leading to methionine restriction and activation of the metabolic sensor AMP-
activated protein kinase (AMPK) in the host, mimicking molecular features of dietary 
restriction36.  
Collectively these studies show that microbial metabolism can alter ageing in the host, 
and identify the microbial and host pathways underlying these effects, demonstrating that 
the worm-bug combined model provides an excellent framework to explore the effects of gut 
microbiota on ageing. They also raise the question if alterations in the bacterial folate and 
methionine can mimic dietary restriction and alter ageing in humans as well, and if the gut 
microbiota can be used for pharmacological interventions. 
 
Bacterially derived NO enhances host lifespan and stress tolerance 
In addition to changes in bacterial metabolism, secreted microbial compounds and signals, 
such as nitric oxide (NO) have been found to promote longevity in C. elegans. NO has many 
important functions, including affecting neurotransmission, immunity and cardiovascular 
function by affecting protein function directly and indirectly via post-translational 
modifications. Although most eukaryotes have endogenous enzymes, NO synthases (NOS), 
that generate NO, C. elegans is unusual in the sense that it has no genes that encode NOS 
and does not produce NO by NOS-dependent synthesis37.  
Since NO is a small molecule that diffuses freely across cellular compartments and 
membranes, NO produced by bacteria can diffuse into worm tissues and affect worm 
physiology. Rather than using the standard laboratory E. coli strain OP50, Gusarov et al37 
used Bacillus subtilis, a soil bacteria that naturally populates the C. elegans’ gut, and 
produces NO37. B. subtilis is known to extend lifespan compared to E. coli38, and Gusarov et 
al showed that the mechanisms of these longevity effects involve bacterial production of NO 
in the worm gut, which diffuses to other tissues and initiates a signalling cascade, resulting 
in a transcriptional response. The transcriptional response involves the longevity genes daf-
16, C. elegans FOXO which acts downstream of reduced IIS, and hsf-1, the C. elegans heat 
shock factor 1. DAF-16 is a transcription factor controlling many aspects of physiology and 
has broad effects on ageing26, while HSF-1 mainly acts by regulating the transcription of 
small heat shock factor proteins. Thus, NO produced by the gut microbiota acts to increase 
lifespan by activating longevity pathways in the host, providing an example of interspecies 
signalling by a small molecule.  
 
Bacterial biofilms promote host health and longevity by reducing IIS 
In most laboratory studies, bacteria are grown in shaken-liquid medium, which favours 
bacteria that grow well in suspension. However, in nature, most bacteria grow in biofilms, 
that is aggregated to each other and to solid surfaces, and embedded within a slimy 
extracellular matrix composed of extracellular polymers, including proteins and 
polysaccharides. Bacteria in biofilms have an unexpectedly high degree of coordinated 
multi-cellular behaviours that have led to the perception of biofilms as “cities” of 
microorganisms. In the biofilms bacteria regulate diverse physiological processes and group 
activities through quorum sensing, a mechanism in which bacterial cells produce, detect and 
respond to small diffusible signal molecule39. 
There is a growing appreciation that, although clearly worthwhile, studies of standard 
planktonic cultures (single cells floating in liquid) provide us with a biased view of microbial 
life. The cells in a biofilm are embedded within an extracellular polysaccharide matrix that 
has been reported to provide the embedded bacteria with protection against a variety of 
environmental stresses, and interactions among microorganisms in a biofilm enhance 
nutrient availability and remove toxic metabolites. Thus, bacteria in a biofilm have different 
characteristics than the same bacteria in isolation40. 
Two recent studies using B. subtilis, a long-serving model for biofilm formation, in 
combination with C. elegans, show that biofilms have beneficial effects on host health and 
longevity, and shines light on some of the mechanisms involved41,42. Donato et al compared 
a wild undomesticated strain of B. subtilis with the standard domesticated strains of B. 
subtilis and E. coli. To promote biofilm formation, they used sporulated forms of B. subtilis, 
which survive the transit through the pharynx and germinate in the worm intestine. The 
domesticated B. subtilis strain increased lifespan and tolerance to different stresses, but all 
these effects were even more pronounced when fed the undomesticated strain. Why does 
the undomesticated B. subtilis strain extend lifespan compared to the domesticated strain? 
The authors found that the undomesticated strain colonised the C. elegans gut to a larger 
extent, and that the effect on both gut colonisation and lifespan depended on the ability to 
form biofilms. Three different strains deficient in the ability to form biofilms due to mutations 
in tasA and epsG, which are key components of the extracellular matrix of the biofilm, and in 
the bslA gene which encodes for an essential hydrophobin responsible for the formation of 
the hydrophobic surface layer that surrounds and protects the biofilm, were tested. The 
mutations suppressed the longevity effects of the undomesticated strain and reduced gut 
colonisation compared with the wildtype undomesticated strain, without having sporulation or 
nutritional effects. Also, the decrease in worm longevity produced by feeding worms each 
biofilm-defective strain correlated with a decreased bacterial proficiency in gut colonisation41.  
Smolentseva et al found similar effects in non-sporulating B. subtilis. They first confirmed 
that non-sporulating B. subtilis also form biofilms inside the C. elegans gut, and then 
compared biofilm-producing B. subtilis with biofilm-deficient B. subtilis mutants, and showed 
that production of biofilm results in increased lifespan and resistance to heat, oxidative 
stress and pathogenic infection, and improved late-life motility. These effects require mtl-1, a 
host gene encoding metallothionein, a small cysteine-rich metal-binding protein, which is 
regulated by DAF-16/FOXO. This study argues that the longevity effects do not require the 
extracellular matrix itself, but rather that it is the metabolic status of the biofilm producing 
bacteria that extends lifespan42. Furthermore, the effects of biofilm have been suggested to 
involve secretion of NO and CSF, a quorum sensing peptide41, but these effects were 
contradicted by Smolentseva et al42.    
Together these studies show that microbial colonisation and biofilms have beneficial 
effects on host longevity and healthspan, and identify some of the host pathways mediating 
the responses to the biofilms. The implication of these studies is that bacterial biofilms, and 
secreted compounds such as NO, act through the classical longevity pathway DAF-
16/FOXO and promote longevity by reducing IIS. Further studies will elucidate the details of 
these interactions and the mechanisms underlying the effect of biofilms on IIS. 
 
High-throughput approaches uncover bacterial effects on host mitochondria 
An important advantage with C. elegans is the possibility to use high-throughput approaches 
to perform large unbiased screens over a range of conditions. Such an approach was used 
to screen the entire Keio E. coli mutant library, covering almost 4000 genes in an E. coli K-
12 BW25113 background, and resulting in the identification of 29 bacterial genes that 
increase lifespan30. The large majority of these bacterial genes act through well 
characterised longevity pathways in the host, including the IIS and mTOR signalling 
pathways, but two of the mutants, ∆hns and ∆lon, increase lifespan independently of known 
longevity pathways. hns encodes a global DNA-binding transcriptional dual regulator, and 
lon a DNA-binding ATP-dependent protease. Both transcriptional regulators suppress 
production of colonic acid (CA), a polysaccharide secreted by many enterobacterial species, 
resulting in high levels of CA secretion in the mutants and longevity in the host. By knocking 
down a number of C. elegans genes and performing imaging and functional analysis, the 
authors showed that bacterial CA regulates host mitochondrial dynamics. CA is taken up by 
the host intestine through endocytosis, increases mitochondrial fission in the intestine, acts 
through mitochondrial respiration and induces transcription of mitochondrial chaperones 
through mitochondrial UPR30.  
Supplementation of CA to wildtype bacteria phenocopies the mutant effect not only in E. 
coli, but also in several other bacterial strains. However, CA supplementation does not 
increase lifespan in the standard laboratory OP50 strain, which is naturally lon deficient and 
already has higher levels of CA, highlighting the importance of the genetic background of 
bacterial strains on longevity. In contrast to NO, biofilms and folate, the longevity effect of 
CA does not require live bacteria, meaning that CA alone is enough to exert its beneficial 
effects and does not act through changes bacterial metabolism30.  
Why improving intestinal mitochondrial homeostasis increases healthspan and lifespan 
remains to be explored, but intestinal health has previously been shown to be important for 
longevity43,44, and this study shows how the gut bacteria can act directly to improve intestinal 
health. The discovery of the influence of CA on host physiology reveals an interesting 
crosstalk between bacterial signalling and mitochondria in animal hosts. Since CA is 
produced in response to stress on the part of the bacteria, worms may have evolved 
response pathways that read bacterial stress in the gut and initiate response pathways as 
means to offset impending adverse conditions45.  
This study is an excellent example of how the worm-bug offers the possibility of using 
high-throughput approaches to perform unbiased screens to identify bacterial determinants 
of late life health, and determine the physiological mechanisms in the host underlying these 
effects. Importantly, this study goes beyond studying host lifespan, and shows that CA not 
only increases lifespan but also suppress age-related disease models and delays the onset 
of muscular mitochondrial fragmentation and locomotor decline. The study also 
demonstrates how worm-bug can be used as a platform to discover mechanisms conserved 
in higher organisms, as CA increases lifespan in Drosophila and promotes mitochondrial 
fragmentation in a murine cell line, opening for the possibility that CA could promote healthy 
ageing in humans. 
Detrimental effects of dysbiosis during ageing  
During ageing, changes in the composition of the human gut microbiota take place46. 
Dysbiosis has been associated not only with ageing but also with many diseases, including 
obesity, type 2 diabetes,  and arthritis1,13,21, but the causality between microbial diversity and 
host health remains unexplored. The mechanisms underlying age-related dysbiosis are likely 
to be complex and multi-factored, and studies using C. elegans offer means to identify 
microbial and host processes contributing to dysbiosis.  
Like humans, C. elegans suffers from age-related dysbiosis, and bacterial proliferation of 
E. coli OP50 in the C. elegans gut has been implicated as a major contributor of mortality47–
49. During its life course, the relationship between C. elegans and E. coli changes. In early 
life, E. coli OP50 mainly acts as a food source, and living, metabolically active bacteria are 
required for normal development and fertility. As the nematodes reach adulthood, E. coli 
OP50 starts proliferating within the gut lumen, and as the animals age, there is a large 
increase in bacterial load in the gut lumen, accompanied by bacterial packing and 
constipation28,48–50.  
A number of studies and approaches confirm that E. coli is pathogenic in late life. 
Inhibiting bacterial growth by antibiotic treatment increases lifespan47–49,51, and animals with 
colonised guts have shorter lifespan than animals with non-colonised guts51 suggesting that 
E. coli proliferates and colonises the gut of the host. Furthermore, inhibiting bacterial 
respiration by introducing mutations in the electron transport chain reduces age-related 
bacterial proliferation and extends lifespan. This effect is not due to dietary restriction or to 
compounds released by the bacteria, but rather by lack of bacterial respiration itself, 
resulting in reduced bacterial growth and suppressed bacterial colonisation of the gut52,53. 
Thus, with age, the relationship to E. coli changes from being necessary and beneficial to 
being detrimental and pathogenic, resulting in dysbiosis, colonisation of the gut and 
mortality. This is not true for all bacterial strains, e.g. the longevity effect of biofilm formation 
by B. subtilis requires bacterial growth, and in this context antibiotics shorten lifespan42. 
Thus, the effect of bacterial proliferation and dysbiosis is dependent on the bacterial species 
and its relationship to the host. 
 
Age-related processes in the host contribute to age-related dysbiosis 
The effect of dysbiosis during ageing is also dependent on age-related processes in the host 
contributing to vulnerability to bacterial proliferation in late life. One such process is 
immunosenescence, the decline of the immune system that occurs during ageing. C. 
elegans has an innate immune system with evolutionarily conserved signalling; anti-
microbial innate immunity is modulated by pathways involving the DAF-16/FOXO 
transcriptional regulator, the PMK-1 p38 MAP kinase, and DBL-1, homologous to human 
transforming growth factor b (TGF-b). Knocking down genes in these pathways results in 
increased bacterial proliferation and decreased host lifespan49 and there is a strong 
correlation between immunity decline, increased dysbiosis and mortality. Thus, the ageing 
process results in decreased efficiency of innate immunity to provide host defence and a 
loss in the capacity to control bacteria within the gut, and dysbiosis, at least partly regulated 
by immunosenescence, plays a role in the determination of host lifespan49.  
 Other host processes are also involved in determining the effect of bacterial proliferation 
during ageing. These relate to the decline of tissues that are in direct contract with the gut 
microbiota, the pharynx and the intestine. The pharynx breaks down bacterial cells during 
feeding, and age-related decline of the pharynx results in increased bacterial load and 
bacterial invasion48,49,53,54. The gut, which digests food and provides a barrier to the external 
world, also exhibits severe decline during ageing55, a process that is likely to contribute to 
increased vulnerability to bacterial pathogens56. Death is accompanied by an increase of 
bacterial density in the pharynx and the proximal intestine, but long-lived animals with 
reduced IIS are protected, and die much later without bacterial colonisation51,54. Collectively, 
these studies show that ageing and death is accompanied by bacterial proliferation and 
tissue invasion, showing that dysbiosis plays an important role in C. elegans ageing, and 
that longevity at least in is be due to resistance to bacteria. An interesting twist to these 
findings is that even though inhibiting bacterial proliferation increases lifespan by 40%, it 
does not increase healthspan in terms of late-life mobility, and animals treated with 
antibiotics spend a large section of their life living in decrepitude51. The relationship between 
between the gut microbiota, host health and ageing is proving to be complex, and there is a 
need to measure more parameters than just survival when performing ageing studies. 
The different host processes contributing to dysbiosis are not necessarily independent. 
Immunosenescence has been suggested to cause pharyngeal and intestinal decline54,56, and 
reduced IIS signalling protects against immunosenescence, pharyngeal and intestinal 
decline38,48,51,55, supporting the idea that the decline of tissues and immune system are 
linked. Thus, dysbiosis is likely to be the result of a negative cycle of tissue aging, 
immunosenescence, and progressive intestinal proliferation of E. coli towards the end of life 
in the host56. 
 
Discovering the C. elegans native microbiome and its effect on life history 
One important question is to what extent studies using laboratory conditions and E. coli 
OP50 reflects the relationship between C. elegans and its microbiota in the wild. Decades of 
studying C. elegans in the lab and feeding it with domesticated E. coli OP50 has left us with 
little understanding of how C. elegans interacts with its natural microbiota. E. coli OP50 was 
chosen as food source because OP50 forms thinner bacterial lawns, easing visual 
inspection of C. elegans, and due to the availability of OP50 in research laboratories, not 
because of any resemblance to microbes in the C. elegans natural habitats57. Thus C. 
elegans has been studied in highly artificial laboratory conditions. 
Our understanding of C. elegans and the relationship to its natural microbiome is now 
changing as the result of three studies published in 2016. Using partly overlapping and 
complementary approaches, these studies used next generation sequencing to characterise 
the native microbiome of C. elegans, either in their natural habitats57,58, or in microcosms 
emulating natural habitats59. The identified C. elegans microbiome is a rich and diverse 
microbiome dominated by Proteobacteria such as Enterobacteriaceae, Pseudomonas, 
Stenotrophomans, Ochrobactrum and Sphingomonas, and Bacteroidetes, Firmicutes, and 
differ from the microbial communities in the soil environment, suggesting that host factors 
influence the microbial composition and that C. elegans has a defined, non-random 
microbiome58,59. Several additional pieces of evidence support this claim. For example, 
microbiomes of worms collected from different sampling sites are more similar to each other 
than to the environmental microbiome58,59, the C. elegans microbiome is distinct compared 
to the microbiome of closely related nematodes60, and animals collected from the wild 
maintain their microbiota when cultivated in the lab58. 
Identification and isolation of the natural microbiome has also allowed the testing of how 
different species affect host fitness in a laboratory setting. Samuel et al established culture 
collections of over 500 wild bacterial strains isolated from the C. elegans natural 
environment, and examined them by growing animals on the individual strains and assaying 
growth rate and responses to a range of stress and immune reporter genes. 78% of the 
strains were found to be beneficial, having a higher growth rate and no induction of stress 
reporters, and 22% to be detrimental, having a slower growth rate and induction of reporters, 
relative to animals grown on E. coli OP50. The effects tended to be genera-specific; several 
Proteobacteria, including Enterobacteriaceae, Gluconobacter, Enterobacter, Providencia 
and most Lactococcus strains were beneficial to C. elegans. Detrimental genera included 
Bacteroidetes, such as Chryseobacterium and Sphingobacterium, and potentially pathogenic 
Gammaproteobacteria (e.g., Xanthomonas and Stenotrophomonas)57. 
Using a different approach, Dirksen et al and constructed an experimental microbiome 
by selecting a subset of 14 isolates representing the most abundant genera of the C. 
elegans microbiome isolated from the wild. Growing animals on the experimental 
microbiome revealed that bacterial strain frequencies within the gut are distinct from the 
strain frequencies of the bacterial culture, e.g. Ochrobactrum and Stenootrophomans 
isolates was only found as small traces in culture, but formed 20% of the bacterial 
communities within C. elegans, and are likely to be part of the C. elegans core microbiome. 
The experimental microbiome increases population size and enhances worm fitness in 
comparison to E. coli OP50, not only in standard laboratory conditions but also under 
different stress conditions. Also in this study analysis of individual bacterial isolates identified 
that the positive effects on population size are likely caused by Proteobacteria58. Future 
studies will identify the positive interactions between Proteobacteria and C. elegans.  
The identification of the native gut microbiome opens for many new possibilities using C. 
elegans to understand interactions between the gut microbiome and the host, including 
aspects shaped by evolution in natural environments, and undetectable in artificial 
environments using E. coli OP50 as the only food source. Considering all the effects on 
fitness already identified in these three initial studies, it would be surprising if the native gut 
microbiota also doesn’t also affect healthspan and longevity. Studies of the native gut 
microbiota are only in its infancy, and coming years will provide us with insight into the role 
the native the gut microbiota plays in the biology of the host, including ageing.  
 
Future perspectives 
Studies in humans and mice suggest that the gut microbiome plays a role in ageing, but this 
complex relationship is very difficult to disentangle in higher animals. Recent studies using 
C. elegans combined with bacterial models are starting to provide mechanistic insight into 
the effects of the gut microbiome on ageing (Table 1). Collectively, they provide with 
examples of how bacterial metabolism promotes host longevity, including bacterial pathways 
such as the folate cycle, methionine metabolism, biofilm formation, suppression of CA 
production and reduction of bacterial respiration. They also strongly suggest that bacterial 
pathways offer a range of possible interventions to improve late life health in the host.  
In addition to microbial pathways, host responses mediating the bacterial effects on 
longevity have been identified and include conserved longevity pathways, such as DAF-
16/FOXO, mTOR and HSF-1 signalling. The activation of longevity pathways by bacteria is 
not exclusive to the laboratory strains E. coli OP50 and B. subtilis. Bacterial strains isolated 
from the human gut, including from human centenarians, have also been shown to activate 
longevity pathways and promote longevity and health in C. elegans61–63. The mechanisms by 
which bacterial signals activate longevity pathways remain to be understood, and will be a 
considerable challenge for future studies, but it is likely that their activation by microbes 
could be exploited to improve health and ageing in humans.  
One remaining question is if the gut microbiota can promote improved ageing through 
pathways other than classical longevity pathways. The majority of the recent studies 
reviewed here have used candidate gene approaches to identify host pathways responding 
to the microbiome, however C. elegans is very well suited for unbiased approaches to 
identify novel pathways. Replacing candidate gene approaches with screening of mutant 
and RNAi libraries will allow identification of novel ways by which the host responds to the 
bacteria. This will be further helped by new automated approaches to measure lifespan and 
healthspan. Recently several automated systems have been developed, including the 
Lifespan Machine, where the survival rates of large populations of animals are monitored 
using flatbed scanners24, and the WormMotel, a microfabricated device for long-term 
cultivation and automated longitudinal imaging of large numbers of individual animals25. 
These and other similar systems have been developed to perform automated lifespan and 
healtshpan experiments with minimum manual input, and can be combined with existing 
scalable automation technology such worm sorters, robotic plate handlers, and chemical 
library screening tools, allowing the study of many bacterial species and pathways and host 
genotypes. Automated approaches also include behavioural tracking which enable high-
throughput measurements of healthspan. For example, The WormMotel allows the 
measurement not only of lifespan, but also of behavioural decline in individual animals. 
Another study used the Multi-Worm Tracker computer-vision system64 to measure stimulated 
locomotion and study end-of-life decrepitude51. C. elegans ageing studies have traditionally 
been focused on measuring lifespan, and the addition of healthspan measurements adds an 
important dimension to our understanding of ageing.   
The biggest remaining question is what physiological effects the gut microbiota 
generates in the host. Most studies have focused on lifespan effects without looking at how 
tissues and cells are affected.  Using a different approach, Han et al identified effects 
resulting from bacterial CA production involving mitochondrial fragmentation and mtUPR in 
the intestine, the tissue in direct contact with the microbiota, and beneficial effects in other 
tissues, including a germline tumor progression model. Also Zhao et al and Podshivalova et 
al looked at the effect of bacteria in tissues and showed that bacterial invasion of the 
pharynx and the intestine occurs during ageing and correlates with death. The continued 
and expanded use of physiologically relevant approaches will shine light on the mechanisms 
through which bacterial pathways act to improve late life health. 
 
Conclusions 
It is becoming clear that the microbiome is linked to human health. Current studies show that 
microbial populations appear in specific disease states and during senescence, and the 
challenge now is to establish if there is a causal link between microbial variation, disease 
and ageing. This requires robust experimental models that allow the systematic manipulation 
of variables to test the multitude of hypotheses arisen during recent years. We are only just 
starting to identify how bacterial pathways affect host biology and ageing, and the factors 
shaping the composition of the gut microbiota. Combining the nematode C. elegans with 
bacterial model organisms allows approaches that cannot easily be used in mammalian 
systems, such as large-scale unbiased screens, automated approaches and in vivo imaging 
in combination with genomics/genetics and metabolomics, allowing the dissection of 
complex interactions and mechanisms between the host and its microbiota. The potential for 
this area of research is immense and during the years to come will see further 
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Table 1. Publications identifying worm-bug interactions resulting in longevity. 
 
